6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp03028 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | MDA-MB-231 | Breast cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03029 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | HCT15 | Colon cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03030 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | PC-3 | Prostate cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03031 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | NCI-H23 | Lung cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03032 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | NUGC-3 | Stomach cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03033 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | ACHN | Renal cancer | GI50 : 4.6–19.6 μg/mL |